Johnson & Johnson
Holdings as of Mar 31, 2026 · filed May 13, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | $258143888 | 39.57% | — | Held |
| 2 | Nanobiotix S.A. | $173607200 | 26.61% | — | Held |
| 3 | Meiragtx Holdings Plc | $57511614 | 8.82% | — | Held |
| 4 | Rapport Therapeutics, Inc. | $55837537 | 8.56% | — | Held |
| 5 | Cvrx, Inc. | $38075185 | 5.84% | — | Held |
| 6 | Contineum Therapeutics Inc. | $25847999 | 3.96% | — | Held |
| 7 | Legend Biotech Corporation | $14735861 | 2.26% | — | Held |
| 8 | Xencor, Inc. | $9021628 | 1.38% | — | Held |
| 9 | Procept Biorobotics Corporation | $8952054 | 1.37% | — | Held |
| 10 | Fate Therapeutics, Inc. | $4054877 | 0.62% | — | Held |
| 11 | Neumora Therapeutics, Inc. | $3606418 | 0.55% | — | Held |
| 12 | Rallybio Corporation | $1371522 | 0.21% | — | NEW BUY |
| 13 | Vor Biopharma, Inc. | $958579 | 0.15% | — | Held |
| 14 | Standard Biotools, Inc. | $286791 | 0.04% | — | Held |
| 15 | Nano-X Imaging Ltd. | $189668 | 0.03% | -75298 | -47.40% |
| 16 | Adicet Bio, Inc. | $155125 | 0.02% | — | Held |
Closed last quarter
Rallybio Corporation
Lyell Immunopharma, Inc.
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.